2019 annual financial data
Ultragenyx Pharmaceutical 2019 Operating margin
Direct answer
Operating margin was -408.98%.
Operating income was -424,173,000 USD and net income was -402,727,000 USD.
Operating cash flow was -345,383,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 103,714,000 USD
- Operating income
- -424,173,000 USD
- Net income
- -402,727,000 USD
- Operating cash flow
- -345,383,000 USD